Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Cullinan Therapeutics Inc
About CGEM
Cullinan Therapeutics, Inc. is a biopharmaceutical company. It has built a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in autoimmune diseases and cancer. Its portfolio includes a range of modalities. Its pipeline includes CLN-978, CLN-619, Zipalertinib (CLN-081/TAS6417), CLN-049, and CLN-617. CLN-978 is a CD19xCD3 T cell engager being developed for autoimmune diseases. CLN-619 is a monoclonal antibody that stabilizes expression of MICA/B on the tumor cell surface to promote tumor cell lysis mediated by cytotoxic innate and adaptive immune cells. Zipalertinib (CLN-081/TAS6417) is an orally available small-molecule, irreversible epidermal growth factor receptor inhibitor. CLN-049 is a FLT3xCD3 T cell engaging bispecific antibody. CLN-617 is a fusion protein combining two potent antitumor cytokines, interleukin-2 and interleukin-12 with tumor retention domains for the treatment of solid tumors.
Find out what a historical investment in Cullinan Therapeutics Inc would be worth today using our CGEM stock calculator.
Market Capitalisation
$871.17M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
988.5K
High today
$15.00
Low today
$14.09
Open price
$14.30
52-week high
$16.74
52-week low
$5.68
Ready to start your investing journey with Stake?
Open an accountHow do I buy CGEM shares in Australia?
Buying CGEM shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Cullinan Therapeutics Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in CGEM
What is the ticker symbol of Cullinan Therapeutics Inc?
The ticker symbol for Cullinan Therapeutics Inc is CGEM.
How much is one share of CGEM?
One share of CGEM is valued at $14.24 as of 20 May 2026.
What is the market capitalisation of Cullinan Therapeutics Inc CGEM?
As of 20 May 2026 Cullinan Therapeutics Inc has a market cap of $871.17M.
What is the 52-week high for Cullinan Therapeutics Inc stock?
The Cullinan Therapeutics Inc 52-week high stock price is $16.74.
What is the 52-week low for Cullinan Therapeutics Inc stock?
The Cullinan Therapeutics Inc 52-week low stock price is $5.68.
Can I buy CGEM shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy CGEM shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in CGEM on Stake
- Buy CGEM from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of CGEM from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
CGEM related stocks